@article{dd806ff0476a4603a8bed1d116e17485,
title = "A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages",
abstract = "The differentiation of human peripheral blood monocytes into macrophages can be reproduced ex vivo by culturing the cells in the presence of colony-stimulating factor 1 (CSF1). Using microarray profiling to explore the role of microRNAs (miRNAs), we identified a dramatic decrease in the expression of the hematopoietic specific miR-142-3p. Up- and down-regulation of this miRNA in primary human monocytes altered CSF1-induced differentiation of monocytes, as demonstrated by changes in the expression of the cell surface markers CD16 and CD163. One of the genes whose expression is repressed by miR-142-3p encodes the transcription factor Early Growth Response 2 (Egr2). In turn, Egr2 associated with its co-repressor NGFI-A (Nerve Growth Factor-Induced gene-A) binding protein 2 (NAB2) binds to the pre-miR-142-3p promoter to negatively regulate its expression. Interestingly, the expression of miR-142-3p is abnormally low in monocytes from patients with the most proliferative forms of chronic myelomonocytic leukemia (CMML), and miR-142-3p re-expression in CMML dysplastic monocytes can improve their differentiation potential. Altogether, miR-142-3p which functions in a molecular circuitry with Egr2 is an actor of CSF1-induced differentiation of human monocytes whose expression could be altered in CMML.",
keywords = "Chronic myelomonocytic leukemia, Egr2, MiR-142-3p, Molecular circuitry, Monocyte-macrophage differentiation",
author = "Brice Lagrange and Martin, {Romain Z.} and Nathalie Droin and Romain Aucagne and J{\'e}r{\^o}me Paggetti and Anne Largeot and Rapha{\"e}l Itzykson and Eric Solary and Laurent Delva and Bastie, {Jean No{\"e}l}",
note = "Funding Information: This study was supported by the Ligue Contre le Cancer (Conf{\'e}rence de coordination inter-d{\'e}partementale, Comit{\'e} de Sa{\^o}ne-et-Loire) (to J.-N.B.), the Conseil R{\'e}gional de Bourgogne (PARI to RGHL team), the ANR (to E.S. and L.D.), the Ligue Nationale Contre le Cancer (to E.S.), the INCa (to E.S.-LACAM), the Fondation de France (Comit{\'e} Leuc{\'e}mie) (to N.D.), and the Association Laurette Fugain (to N.D.). B.L. was supported by fellowships from the Minist{\`e}re de l'Enseignement Sup{\'e}rieur et de la Recherche of France (MESR) , the Association pour la Recherche sur le Cancer (ARC) , and the Soci{\'e}t{\'e} Fran{\c c}aise d'H{\'e}matologie (SFH) , R.Z.M. by fellowships from the MESR, R.A. by fellowships from the Ligue de Sa{\^o}ne-et-Loire contre le Cancer, the ARC, and the SFH, J.P. by fellowships from the MESR and the ARC, A.L. by fellowships from the Inserm associated with the Conseil R{\'e}gional de Bourgogne and the SFH, and R.I. by Inserm. ",
year = "2013",
month = aug,
day = "1",
doi = "10.1016/j.bbamcr.2013.04.007",
language = "English",
volume = "1833",
pages = "1936--1946",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
number = "8",
}